This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Euroimmun Medizinische Labordiagnostika Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Swantje Mindorf: Innovator in Diagnosing Membranous Nephropathy
Introduction
Swantje Mindorf is a notable inventor based in Ziethen, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of membranous nephropathy. His innovative work has led to the development of a patented method that enhances the accuracy of diagnosing this condition.
Latest Patents
Swantje Mindorf holds a patent for a method and reagents for diagnosing membranous nephropathy. This patent includes a diagnostically useful carrier coated with a recombinant polypeptide comprising SEQ ID NO: 1. It also features an isolated autoantibody that specifically binds to a polypeptide having SEQ ID NO: 1. The patent outlines a kit that comprises the carrier and a method for diagnosing membranous nephropathy by detecting the presence of the autoantibody in a liquid sample from a subject. This innovative approach provides a valuable tool for medical professionals in diagnosing this complex condition.
Career Highlights
Swantje Mindorf is associated with Euroimmun Medizinische Labordiagnostika AG, a company known for its advancements in medical laboratory diagnostics. His work at Euroimmun has allowed him to collaborate with other experts in the field, further enhancing the impact of his innovations.
Collaborations
Swantje has worked alongside talented colleagues, including Inga-Madeleine Dettmann and Christian Probst. These collaborations have contributed to the development of effective diagnostic tools and methodologies.
Conclusion
Swantje Mindorf's contributions to the field of medical diagnostics, particularly through his patent for diagnosing membranous nephropathy, highlight his role as an innovator. His work continues to influence the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
